Trials / Conditions / Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2 Infection)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2 Infection)
3 registered clinical trials studyying Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2 Infection).
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19 NCT05629962 | Atea Pharmaceuticals, Inc. | Phase 3 |
| Terminated | A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpa NCT04847141 | Grifols Therapeutics LLC | Phase 3 |
| Unknown | Antibodies Responses to COVID-19 Infection in Hospitalized Patients NCT04520880 | Imam Abdulrahman Bin Faisal University | — |